Heron Therapeutics Inc (HRTX)

EBITDA Growth

-184.58%

Quarterly · Period ending:

HRTX logo

HRTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-184.58%
HRTX Quarterly EBITDA YoY % (200.00% → -184.58%)
High-resolution chart · PNG

HRTX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-184.5763%
-305.6972%
-116.224%
-271.1176%
78.3988%
293.1866%
256.4953%
84.1175%
80.1694%
94.0468%
77.1794%
42.4348%
25.8009%
49.2615%
54.0197%
20.2346%
7.6193%
-22.9528%
7.9761%
10.3463%
-9.5938%
1.4162%
-12.4891%
-67.8172%
-7.2475%
18.8688%
-19.1443%
17.0685%
-33.1335%
-24.4608%
29.8837%
-1.1953%
7.4923%
-5.389%
-33.5295%
13.7487%
2.7374%
-48.0619%
-50.8614%
-112.5381%
-87.4316%
-63.6679%
-50.9617%
-18.6832%
-22.3776%
-17.4338%
-47.2515%
-49.5149%
-23.3708%
-35.6884%
-60.1189%
-109.5651%
-248.8587%
-168.8003%
-110.4514%
-48.3193%
-190.2945%
-272.3757%
-142.0428%
-156.0759%
58.9448%
54.8146%
16.3853%
-40.4444%
6.0418%
2.4356%
45.9909%
81.7696%
36.9526%
58.8782%
51.7469%
-17.8571%
-52.6211%
-15.0074%
-34.9633%
-35.6125%
14.2888%
-41.1942%
-140.8919%
-110.1796%
-85.7595%
-258.0699%
-3.0342%
2.4947%
-7.7579%
52.4901%
-59.8753%
-73.6406%
-27.2925%
-42.1348%
-392.4915%
24.548%
-21.7305%
-49.3289%
84.8579%
25.5694%
0.5256%
9.2846%
-10.3193%
-117.0787%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.